TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Protara Therapeutics (NASDAQ:TARA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Protara Therapeutics to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive NMIBC Patients at the ASCO Genitourinary Cancers Symposium
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
Protara Therapeutics (NASDAQ:TARA) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Form 424B7 Protara Therapeutics,
Form 4 Protara Therapeutics, For: Jan 26 Filed by: Fry Hannah
Form 4 Protara Therapeutics, For: Jan 26 Filed by: Zummo Jacqueline
Form 4 Protara Therapeutics, For: Jan 26 Filed by: Fabbio Patrick
Form 4 Protara Therapeutics, For: Jan 26 Filed by: Shefferman Jesse
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.